Skip to main content
Scope Fluidics S.A. logo

Scope Fluidics S.A. — Investor Relations & Filings

Ticker · SCP ISIN · PLSCPFL00018 LEI · 259400EUNFX4E2BEHU15 WAR Professional, scientific and technical activities
Open in API
Filings indexed 518 across all filing types
Latest filing 2025-11-02 Major Shareholding Noti…
Country PL Poland
Listing WAR SCP

About Scope Fluidics S.A.

https://scopefluidics.com/

Scope Fluidics S.A. is a biotechnology company that develops innovative medical diagnostic solutions based on microfluidic technologies. The company's business model involves incubating projects within special-purpose vehicles (SPVs) with the goal of selling them to global strategic partners. Its primary project, developed by its subsidiary Bacteromic Sp. z o.o., is the BACTEROMIC system. This automated system provides rapid, comprehensive antimicrobial susceptibility testing (AST) to address the challenge of antibiotic resistance. Previously, the company developed the PCR|ONE system for rapid molecular diagnostics through its Curiosity Diagnostics SPV, which was acquired by Bio-Rad in 2022. The company focuses on creating fast, effective, and accessible diagnostic tools to improve healthcare outcomes.

Recent filings

Filing Released Lang Actions
Zawiadomienie w trybie art. 69 Ustawy o ofercie
Major Shareholding Notification Classification · 100% confidence The document is a formal notification ('Zawiadomienie') regarding a change in shareholding, specifically citing 'art. 69 ust. 1 lub 2' of the Polish Act on Public Offering. It details the acquisition of shares by 'TRIGON INVESTMENT BANKING' in 'SCOPE FLUIDICS S.A.', resulting in a 16.23% stake. This is a classic major shareholding notification, which corresponds to the 'MRQ' category.
2025-11-02 Polish
Otrzymanie zawiadomienia w trybie art. 69 ustawy o ofercie - Content (PL)
Major Shareholding Notification Classification · 100% confidence The document is a very short notification (151 characters) stating that the company has received a notification regarding a change in shareholding (art. 69 Ustawy o ofercie) and that this notification is attached to the report. This fits the definition of a Major Shareholding Notification (MRQ) as it pertains to the disclosure of significant share ownership changes.
2025-11-02 Polish
Zawarcie umów objęcia akcji serii K, dookreślenie wysokości kapitału zakładowego i zmiana Statutu Spółki - Content (PL)
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Scope Fluidics S.A. regarding the increase of its share capital through the issuance of new series K shares. It details the specific changes to the company's articles of association (Statut) and provides a breakdown of the share capital before and after the issuance. This falls directly under the category of share issuance and capital changes.
2025-10-31 Polish
Zawiadomienie od Szymona Ruty
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person discharging managerial responsibilities (PDMR), specifically the Vice President of the Management Board (Szymon Ruta) of Scope Fluidics S.A. It explicitly references Article 19(1) of the Market Abuse Regulation (MAR). This type of disclosure, detailing the sale of shares by an insider, is classified as a Director's Dealing.
2025-10-31 Polish
Otrzymanie zawiadomienia od Członka Zarządu w trybie art. 19 MAR - Content (PL)
Director's Dealing Classification · 100% confidence The document is a short notification regarding a disclosure received from a Vice President under Article 19 of the Market Abuse Regulation (MAR). This is a standard notification of a director's transaction or dealing, which is a specific regulatory requirement. Given the nature of the disclosure regarding an insider's notification, it falls under the category of Director's Dealing.
2025-10-31 Polish
Zawiadomienie od Roberta Hołysta
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person discharging managerial responsibilities (PDMR), specifically a member of the Supervisory Board (Robert Hołyst), as required by Article 19 of the Market Abuse Regulation (MAR). It details the sale of shares in Scope Fluidics S.A. This fits the definition of a Director's Dealing (DIRS) report.
2025-10-31 Polish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.